Department of Neuroscience, The Scripps Research Institute Florida, Jupiter, Florida.
Basic Clin Pharmacol Toxicol. 2020 Jun;126 Suppl 6(Suppl 6):88-95. doi: 10.1111/bcpt.13228. Epub 2019 Apr 15.
Heterotrimeric G proteins are essential mediators of G protein-coupled receptors (GPCRs) signalling to intracellular effectors. There is a considerable diversity of G protein subunits that channel signals initiated by GPCRs into specific outcome. In particular, mammalian genomes contain 16 conserved genes encoding G protein α subunits with unique properties. Of four Gα subfamilies (Gi/o, Gq, Gs and G12/13), members of the G12/13 group have received considerable attention for their roles in carcinogenesis. However, our ability to study activation of G12/13 by GPCRs with the power to distinguish between the two subunits is limited. Here, we present an adaptation of the bioluminescence resonance energy transfer (BRET)-based assay to specifically monitor activity of Gα12 in living cells. In this kinetic assay, agonist-induced release of Venus-tagged Gβγ subunits from Gα12 is followed in real time using nano-luciferase (Nluc)-tagged BRET donor. Using this assay, we characterized bradykinin B2 receptor (BDKRB2) and found that the receptor couples to Gα12 in addition to Gαo, and Gαq, but not to Gαs. We demonstrated the utility of this assay to quantify rates of G protein activation and inactivation as well as performing dose-response studies while rank ordering signalling via individual Gα subunits. We further showed the utility of this assay to other GPCRs by demonstrating Gα12 coupling of cholecystokinin A receptor (CCKAR). Introduction of the Gα12-coupling BRET assay is expected to accelerate characterization of GPCR actions on this understudied G protein.
三聚体 G 蛋白是 G 蛋白偶联受体 (GPCR) 向细胞内效应器传递信号的重要介质。G 蛋白亚基具有相当大的多样性,可将 GPCR 引发的信号传入特定的结果。特别是,哺乳动物基因组包含 16 个编码具有独特特性的 G 蛋白α亚基的保守基因。在四个 Gα亚家族 (Gi/o、Gq、Gs 和 G12/13) 中,G12/13 亚家族的成员因其在致癌作用中的作用而受到广泛关注。然而,我们研究 GPCR 激活 G12/13 的能力受到限制,无法区分两个亚基。在这里,我们提出了一种基于生物发光共振能量转移 (BRET) 的测定方法的改编,该方法可专门监测活细胞中 Gα12 的活性。在这种动力学测定中,使用纳米荧光素酶 (Nluc) 标记的 BRET 供体实时跟踪激动剂诱导的 Venus 标记的 Gβγ亚基从 Gα12 中的释放。使用该测定法,我们对缓激肽 B2 受体 (BDKRB2) 进行了特征描述,发现该受体除了与 Gαo 和 Gαq 偶联外,还与 Gα12 偶联,但与 Gαs 不偶联。我们证明了该测定法可用于量化 G 蛋白的激活和失活速率,以及进行剂量反应研究,同时对单个 Gα亚基的信号转导进行排序。我们通过证明胆囊收缩素 A 受体 (CCKAR) 的 Gα12 偶联进一步证明了该测定法在其他 GPCR 中的应用。引入 Gα12 偶联 BRET 测定法有望加速对这种研究较少的 G 蛋白的 GPCR 作用的表征。